Device for an electrophysiology procedure

Abstract

A quantum cardiac electrophysiology device comprising an array of consumable half-ferromagnetic active electrodes connected to an array of semiconductor of half-ferromagnetic selector switches over an array of half-ferromagnetic resistors to a neutral charges out of the heart, by casting and/or inking the arrhythmic substrate of an arrhythmia by the electrophysiology quantum entan- glement of said arrhythmic substrate.

Claims

1. A quantum cardiac electrophysiology device, comprising: A consumable active electrodes array, wherein each said consumable electrode may be configured to be half-ferromagnetic; A first selector switch array (156-array) commutatively connected to the consumable active electrode array, wherein each first selector switch from said first selector switch array is further on configured to be a first magnetic tunnel selector switch wherein said first magnetic tunnel selector switch may be configured to be semiconductor, half-ferromagnetic or both; A second selector switch array (155-array) commutatively connected to the consumable active electrode array, wherein each second selector switch from said second selector switch array is further on configured to be a second magnetic tunnel selector switch wherein said second magnetic tunnel selector switch may be configured to be semiconductor, half-ferromagnetic or both; A resistor array (151-array), bijectively connected to said second selector switch array (155-array) wherein said half-ferromagnetic resistors are in anti-parallel state to the heart magnetic field provided by the myocardial band; A sensor device array (160-array) configured to be bijectively connected to said first selector switch array (156-array).

2. A method of inking a collapsed arrhythmic substrate wherein said inking is the decay of at least part of at least one consumable active electrodes of claim 1 selectively connected to at least one said first magnetic tunnel selector switch of claim 1, wherein said decay within said collapsed arrhythmic substrate is provided when at least one negative differential resistance (NDR) of at least one biological qubit of said collapsed arrhythmic substrate was measured.

3. A method of inking a collapsed arrhythmic substrate with a half-ferromagnetic staining ink wherein said half-ferromagnetic staining ink is provided and is delivered from an external can to said collapsed arrhythmic substrate through the internal lumen of a mapping catheter or optionally through the lumen of an additional mapping catheter when at least one negative differential resistance (NDR) of at least one biological qubit of said collapsed arrhythmic substrate was measured.

4. A method of inking a not yet collapsed arrhythmic substrate with a half-ferromagnetic staining ink, wherein said half-ferromagnetic staining ink is provided and configured to selectively collapse the substrate where at least one negative differential resistance (NDR) of at least one biological qubit of said not yet collapsed substrate is provided as said half-ferromagnetic staining ink applies and is entangled at said not yet collapsed arrhythmic substrate, wherein said half-ferromagnetic staining ink is delivered into the vascular system or into the pericardial space using conventional access points.

5. The methods of claims 2-4 wherein the inked-in collapsed arrhythmic substrate is a quantum built-in implantable cardiac device, locally entangled within said collapsed arrhythmic substrate and being configured to be programmable by quantum magnetic interference or SQUID devices.

Description

DESCRIPTION OF DRAWINGS

[0012] In the following, the invention will be described by way of example, without limitation of the general invention concept, on examples of embodiments with reference to the drawings.

[0013] FIG. 1 shows a catheter device,

[0014] FIG. 2 shows a schematic diagram of the quantum electrophysiology device-catheter device assembly, wherein FIG. 2.1 shows the second selector switch array (155-array) bijectively connected to the resistor array (151-array) and the first selector switch array (156-array), bijectively connected to the sensor device array (160-array),

[0015] FIG. 3 shows the built-in quantum implantable cardiac device 300 within a sectional view of a heart, one intra-pericardial implantation although being provided, is not graphically displayed,

[0016] FIG. 4 shows the VI (voltage-current) distribution at the level of the arrhythmic substrate, wherein FIG. 4.1 depicts a NDR domain array at the level of the arrhythmic substrate.

[0017] List of reference numerals

[0018] 110: catheter device

[0019] 120: distal end

[0020] 121-124: consumable distal electrode array

[0021] 126: low resistive wires

[0022] 130: proximal end

[0023] 131: connectors

[0024] 140: flexible shaft

[0025] 141: flexible wire

[0026] 150: control unit

[0027] 151-array: resistor array

[0028] 156-array: first magnetic tunnel selector switch array

[0029] 155-array: second magnetic tunnel selector switch array

[0030] 160-array: sensor device array

[0031] 161-array: voltage meter array

[0032] 161-array: current meter array

[0033] 170: neutral electrode

[0034] 180: handle

[0035] 181, 182: operating elements

[0036] 200: heart

[0037] 300: quantum built-in implantable cardiac device

[0038] 310: tip assembly

[0039] 360: additional mapping catheter

[0040] Although the invention has been illustrated and described in detail by the embodiments explained above, it is not limited to these embodiments. Other variations may be derived by the skilled person without leaving the scope of the attached claims.

In addition, numerical values applied (number of consumable active electrodes, units within arrays) may include the exact values as well as a tolerance interval, unless this is explicitly excluded.
Features shown in the embodiments, in particular in different embodiments, may be combined or substituted without leaving the scope of the invention.